Vergoeding 2015-2019 voor ATC-subgroep N02CC : Selectieve serotonine-agonisten
- Raming voor de totale Zvw-populatie
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| N02CC01 Sumatriptan (Imigran ®) | 13.306.500 | 12.950.900 | 11.958.200 | 12.109.300 | 12.606.700 |
| N02CC02 Naratriptan (Naramig ®) | 175.640 | 178.780 | 175.680 | 171.400 | 164.820 |
| N02CC03 Zolmitriptan (Zomig zip ®) | 284.370 | 254.980 | 249.470 | 277.360 | 427.300 |
| N02CC04 Rizatriptan (Maxalt ®) | 1.943.600 | 1.680.400 | 1.554.300 | 1.633.100 | 1.521.800 |
| N02CC05 Almotriptan (Almogran ®) | 537.310 | 447.980 | 417.750 | 398.760 | 387.500 |
| N02CC06 Eletriptan (Relpax ®) | 1.791.200 | 1.928.500 | 1.912.800 | 1.919.900 | 1.883.900 |
| N02CC07 Frovatriptan (Fromirex ®) | 1.524.200 | 1.032.100 | 709.300 | 717.820 | 887.720 |
| Totaal | 19.562.820 | 18.473.640 | 16.977.500 | 17.227.640 | 17.879.740 |